Marsh McLennan stock holds firm after strong earnings

Marsh McLennan stock (ISIN US5717481023) closed near USD 185.80 while the consensus target stood at USD 203.50 on September 5, 2026. The group also reported second-quarter 2026 EPS of USD 2.96 and revenue of USD 7.28 billion, both above expectations.

Q2 numbers set the tone

According to a MarketBeat report, Marsh McLennan beat the consensus EPS estimate of USD 2.89 by USD 0.07 and grew quarterly revenue by 6.2 percent year over year to USD 7.28 billion on July 21, 2026. The same report said the company posted a 14.24 percent net margin and 32.67 percent return on equity.

That combination matters for investors because the revenue beat was paired with a profit beat, not just a top-line rise. MarketBeat also cited a current fiscal-year EPS view of USD 10.44, which frames the stock against a still-healthy full-year earnings base.

Analysts stay cautious

On September 5, 2026, MarketBeat said analysts kept Marsh McLennan at Hold with an average target price of USD 203.50. The gap to the cited share price of USD 185.80 implies about 9.5 percent upside to that target.

A separate note in the same update said UBS lifted its target to USD 216.00 from USD 212.00 and kept a Buy rating, while Cantor Fitzgerald raised its target to USD 218.00 from USD 210.00 and kept an Overweight view. Together, those numbers show a still split read on valuation after the earnings release.

Insurance and consulting mix

Marsh McLennan's business model still leans on insurance broking, risk advisory, and consulting, so margin discipline matters as much as revenue growth. The July 21, 2026 quarter showed both: USD 7.28 billion in revenue and a 14.24 percent net margin.

Stock level to watch

With the share price at USD 185.80 on September 5, 2026, the stock traded below the USD 203.50 consensus target and below the higher USD 216.00 to USD 218.00 analyst range cited in the same update. That leaves valuation, not growth alone, as the key debate.